Credelio Plus 56.25 mg Tablet (Chewable) is a Health Canada–registered veterinary drug (DIN 02525674) held by Elanco Canada Limited, containing Lotilaner. Health Canada lists its status as Marketed (status date 04 Aug 2022). Nexara Health has matched 53 registrations of Lotilaner across 5 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02525674 |
|---|---|
| Brand name | Credelio Plus |
| Active ingredient | Lotilaner |
| Strength | 56.25 mg |
| Dosage form | Tablet (Chewable) |
| Route | Oral |
| Company | Elanco Canada Limited |
| Status | Marketed — 04 Aug 2022 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Lotilaner registered in other markets
53 registrations of the same molecule in 5 national registries outside Canada (first 30 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Poland | Credelio 900 mg | Elanco GmbH | 900 mg | Tabletka do rozgryzania i żucia | URPL RPL | |
| Denmark | AdTab til hunde >11-22 kg | Elanco GmbH | 450 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | AdTab til hunde >2.5-5.5 kg | Elanco GmbH | 112 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | AdTab til hunde >22-45 kg | Elanco GmbH | 900 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | AdTab til hunde >5.5-11 kg | Elanco GmbH | 225 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | AdTab til hunde 1.3-2.5 kg | Elanco GmbH | 56 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | AdTab til katte >2.0-8.0 kg | Elanco GmbH | 48 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | AdTab til katte 0.5-2.0 kg | Elanco GmbH | 12 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| Denmark | Credelio | Elanco GmbH | 56 mg | tyggetabletter | Central | Laegemiddelstyrelsen |
| European Union (EMA) | AdTab (previously Lotilaner Elanco) | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Credelio | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Lotimax | — | Authorised | EMA centrally authorised | ||
| Finland | AdTab | Elanco GmbH | 225 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | AdTab | Elanco GmbH | 900 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | AdTab | Elanco GmbH | 112 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | AdTab | Elanco GmbH | 56 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | AdTab | Elanco GmbH | 450 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | AdTab | Elanco GmbH | 12 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | AdTab | Elanco GmbH | 48 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Credelio | Elanco GmbH | 48 mg | purutabletti | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Poland | AdTab | Elanco GmbH | 900 mg | Tabletka do rozgryzania i żucia | URPL RPL | |
| Poland | Lotimax | Elanco GmbH | 450 mg | Tabletka do rozgryzania i żucia | Bezterminowe | URPL RPL |
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | lotilaner | Elanco US Inc. | Tablet, Chewable | FDA NDC | ||
| United States | Lotilaner | PROCOS SpA | Powder | FDA NDC |
See every manufacturer of Lotilaner worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Credelio Plus (DIN 02525674) marketed in Canada?
Yes. Health Canada lists DIN 02525674 as Marketed as of 04 Aug 2022.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Lotilaner registered outside Canada?
Yes — Nexara Health has matched 53 registrations in 5 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02525674, status date 2022-08-04; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02525674, status date 2022-08-04; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02525674, status date 2022-08-04; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.